Hyperspectral Drusen Classification

Clinical trial NCT06860555 · COMPLETED

Trial details

NCT number: NCT06860555
Sponsor: Optina Diagnostics Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Dry Age Related Macular Degeneration

Start date: 2022-11-08
Primary completion: 2023-08-15
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.